Pharmaceutical Anti-Counterfeiting Technologies (Authentication Technologies & Track & Trace Technologies) Market 2015-2025

Jul 23, 2015, 13:12 ET from Research and Markets

DUBLIN, July 23, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025" report to their offering.

The Pharmaceutical Anti-Counterfeiting Technologies, 2015-2025' report provides a comprehensive study of the growing market of anti-counterfeiting technologies being used in the pharmaceutical industry. This study provides extensive details on technologies which offer overt and covert features to enable verification of drugs. In addition, it reviews the different track and trace technologies which enable tracking of a product through the supply chain. Counterfeiting of products is a big concern in several industries such as electronics, cosmetics, tobacco, wine & spirits and fast moving consumer goods.

Specifically, within the pharmaceutical market, the magnitude of the problem is relatively high as it has a direct impact on the health of the wider community. It is worth highlighting that the pharmaceutical market is highly attractive for counterfeiters due to several benefits such as high price of patented drugs, lack of proper legislations and high demand of medicines compared to their supply. The primary goal of anti-counterfeiting technologies is to prevent counterfeiting of products; this is done by making it difficult to copy patent protected drugs as well as preventing entry of substandard or fake drugs into the product supply chain.

The market can be categorised into two segments, Authentication Technologies (the technologies providing overt and covert security features) and Track & Trace Technologies (the technologies facilitating visibility of products throughout the supply chain). Specifically in the Authentication segment, technologies providing covert security features are very popular and occupy a major share in of the overall authentication market. These technologies are very difficult to mimic and require special instruments / devices for verification of drugs by the manufacturers.

Managing supply chain, especially in case of pharmaceutical industry, is a big challenge. Pharmaceuticals supply chains are highly complex and therefore make it an ideal target for counterfeiters. However, recently many developments have taken place to overcome this challenge. Several countries across the globe have passed legislations, making it mandatory to implement serialisation by the manufacturers. Serialisation is being thought as a one stop solution to prevent counterfeiting in the pharmaceutical industry by securing the supply chain.

The field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. The overall interest continues to rise as is evident from the number of counterfeit incidents and various laws and legislations being passed throughout the world. Small companies that have developed anti-counterfeiting technologies are likely to play a very active role in the near future.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Authentication: Key Players and Technologies

6. Track And Trace: Key Technologies and the Concept of Serialisation

7. Market Forecast

8. SWOT Analysis

9. Interview Transcripts

10. Conclusion

11. Appendix 1: Tabulated Data

12. Appendix 2: Companies and Organisations Listed

Companies Mentioned - 35 of the 125 Companies Featured

- 3M

- 3S Simons Security Systems

- ACG-Worldwide

- Acsis

- Alcan Packaging

- Alien Technology

- Alliance for Safe Online Pharmacies

- AlpVision

- Amcor

- Amgen

- Applied DNA Sciences

- Atlantic Zeiser

- Authentix

- Avery Dennison

- Axway

- Ball Packaging

- Bilcaretech

- Biocode

- Bosch Packaging Technology


- Catalent Pharma

- Cellular Bioengineering

- Central Anti-Counterfeiting Laboratory

- Chesapeake (Acquired by The Carlyle Group)

- Cognizant

- Confidex

- Coresonant

- Covectra

- Deutsche Welle

- DiNova Venture Capital

- DNA Technologies

- Dupont

- Eli Lilly and Company

- EM Microelectronics

- European Alliance of Access to Safe Medicines

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets